Agenus/LinkedIn
May 29, 2025, 12:19
Agenus Addresses Rising Colorectal Cancer Rates in Younger Adults
Agenus shared a post on LinkedIn:
“Colorectal cancer is being diagnosed in younger people—those under 50—at an alarming rate, often requiring intensive treatments that can lead to lasting side effects impacting patients’ quality of life.
Our team remains dedicated to advancing immunotherapy research with the goal of expanding treatment options that may help improve outcomes for patients across all age groups.”
Agenus raised awareness about the growing incidence of colorectal cancer among individuals under 50 and reaffirmed its focus on immunotherapy development to broaden treatment choices and improve patient outcomes.
More posts featuring Agenus.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 20, 2025, 02:19
Jun 19, 2025, 16:01